New tissue engineering techniques, the possibility of extracting cells from our organs and cultivating them in vitro or using mesenchymal progenitor cells or stem cells open up new horizons in the treatment of trauma and joint conditions.

Dr. Alberto Gobbi of Milan was among the first to deal with biotechnologies for the treatment of injuries in athletes.

In particular, some frequent pathologies for athletes such as muscle contusions, fractures, cartilage lesions, or even chronic tendinitis and infected wounds can have quicker solutions, thanks to the use of “growth factors” and mesenchymal cells obtained from the blood and marrow tissue of the patient himself.

The method consists of taking a modest amount of blood (about 60 cc.) or bone marrow from the iliac crest, putting it in a special centrifuge (Gravitational Platelet Separation) that divides the different fractions of the blood. Then after appropriate filtration, the activated platelet fraction or the appropriately gelled mesenchymal cells are reintroduced into the lesion area, stimulating natural healing. In many cases, it is a simple injection or surgical arthroscopy. Thanks to these technologies, it is possible to exponentially increase the concentration of growth factors that are already present in our body, but often in limited quantities.

A cartilage lesion rapidly leads to arthrosis, so the possibility of regenerating a cartilage-like tissue in order to delay joint aging is of great interest. Preliminary studies show a positive response even in subjects affected by arthropathies that are difficult to treat with conventional therapies.

In the case of PDGF (platelet derived growth factors), we are faced with real “catalysts” of the healing processes. Growth factors represent an extremely interesting and current PDGF chapter and the preliminary results are surprising.

At the O.A.S.I (Orthopaedic Arthroscopic Surgery International) Medical Center in Milan under the guidance of Dr. Alberto Gobbi, foreign researchers are working on studies on mesenchymal cells and growth factors that are used in sports traumatology and in the treatment of chronic degenerative conditions. We have recently started joint studies with research groups in the USA where the first studies were conducted on racehorses affected by post-traumatic or wear-related cartilage lesions. Also at the Rizzoli in Bologna, a research protocol has been started also in patients with arthritic degeneration.

In conclusion, another important chapter opens in the treatment of sports injuries that in the past could mean the end of an athlete’s career and also result in poor quality of life in the patient affected by chronic degenerative arthropathies.